['Atorvastatin can downregulate the expression of receptor for advanced glycation end products (RAGE) in the aortas of diabetic rats. However, its effect on healthy rats remains unclear. The aim of this study was to observe the direct impact of atorvastatin on advanced glycation end products- (AGEs) induced RAGE expression in healthy Sprague Dawley (SD) rats.', "SD rats received AGE-BSA (20\xa0mg/kg/day or 40\xa0mg/kg/day), dual treatment (AGE-BSA 40\xa0mg/kg/day and atorvastatin 20\xa0mg/kg/day) or no treatment for 12 and 24\xa0weeks, respectively. The deposition of AGEs and expression of RAGE in the animals' aortas were assessed by Quantitative RT-PCR, immunohistochemistry, and western-blot tests. Serum levels of AGEs were measured using ELISA.", "AGE-BSA upregulated the serum level of AGEs, deposition of AGEs, and expression of RAGE in aortas in a time- and dose-dependent way that can accelerate the development and progression of atherosclerosis. These upregulations could be significantly attenuated by atorvastatin in the absence of its lipid-lowering effects. These data provide further evidence for the novo mechanism of atorvastatin's pleiotropic effect."] Does atorvastatin inhibit the expression of RAGE induced by advanced glycation end products on aortas in healthy Sprague-Dawley rats?